Antiherpetic PHARMACEUTICAL COMPOSITION AND METHOD OF PREPARATION OF THE FORMULATION based on it

摘要

1.u0444u0430u0440u043cu0430u0446u0435u0432u0442u0438u0447u0435u0441u043au0430u00a0 u043fu0440u043eu0442u0438u0432u043eu0433u0435u0440u043fu0435u0442u0438u0447u0435u0441u043au0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0, u0432u043au043bu044eu0447u0430u044eu0449u0430u00a0 u0432u0438u0440u0438u043eu043du043du044bu0439 u0432u0430u043au0446u0438u043du043du044bu0439 u0430u043du0442u0438u0433u0435u0440u043fu0435u0442u0438u0447u0435u0441u043au0438u0439 drug, which u0441u043eu0434u0435u0440u0436u0430u0442u0441u00a0 simple herpes viruses. u043eu0442u0438u043fu043eu0432 1 or 2, u0438u043du0430u043au0442u0438u0432u0438u0440u043eu0432u0430u043du043du044bu0435 u0444u043eu0440u043cu0430u043bu0438u043du043eu043c or - radiation and u0438u043cu043cu0443u043du043du043eu043au043eu043cu043fu0435u0442u0435u043du0442u043du043eu0435 substance u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 that contains u0438u043cu043cu0443u043du043eu043cu043eu0434u0443u043bu00a0u0442u043eu0440 u043fu043eu043bu0438u043eu043au0441u0438u0434u043eu043du0438u0439, supplementary the contains valine and lysine, and the combination u0441u043eu0441u0442u043eu00a0u0449u0443u044e not lessthe two amino acids selected from the group of: phenylalanine, leucine, alanine, threonine, histidine, arginine, methionine at the following ratio components:;u0430u043du0442u0438u0433u0435u0440u043fu0435u0442u0438u0447u0435u0441u043au0438u0439 drug - 106 - 107 u0431u043bu00a0u0448u043au043eu043eu0431u0440u0430u0437u0443u044eu0449u0438u0445;units / ml of suspension;u043fu043eu043bu0438u043eu043au0441u0438u0434u043eu043du0438u0439 0.03, 0.06 g;valine 0.18 to 0.25 g;lysine, 0.15 and 0.30 g;u043au043eu043cu0431u0438u043du0430u0446u0438u00a0 of metabolic;amino acids 0.12 - 0.27 g;u0444u0438u0437u0438u043eu043bu043eu0433u0438u0447u0435u0441u043au0430u00a0 u0436u0438u0434u043au0430u00a0 wednesday to 100 ml;2. u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 that additionally contains human albumin of 0.22 - 0.24 g in 100 ml.;3. u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 that additionally contains one or more water and u0436u0438u0440u043eu0440u0430u0441u0442u0432u043eu0440u0438u043cu044bu0445 vitamins selected from the group of: thiamine, riboflavin, u043du0438u043au043eu0442u0438u043du0430u043c id, pyridoxine, u0430u0441u043au043eu0440u0431u0438u043du043eu0432u0430u00a0 acid, retinol, tocopherol, or their mixture in the total number of compositions from 0.05 to 3.5%.;4. method u043fu0440u0438u0433u043eu0442u043eu0432u043bu0435u043du0438u00a0 u0441u0443u043fu043fu043eu0437u0438u0442u043eu0440u0438u00a0 based pharmaceutical composition adopted in u043fu043f.1 - 3, including the standard technology of active to u043eu043cu043fu043eu043du0435u043du0442u043eu0432 and cocoa butter, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, as an active pharmaceutical composition on the u0432u043du043eu0441u00a0u0442 u043fu043f.1 - 3 and one or more elements (doe), you foul of group, zinc, chromium, selenium and nickel.;5. method for p.4, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, mae u0432u043du043eu0441u00a0u0442 as soluble u0445u0435u043bu0430u0442u043du044bu0445 forms of 0.01 - 0.08% to the total mass of the composition.